Everything listed here is Research Use Only (RUO). Not for human or animal consumption.
Metabolic & Weight Management · Philadelphia, PA
Semaglutide is documented by ReVia for metabolic and endocrine research labs in Philadelphia and across the Northeast's research corridor, including Cherry Hill, Wilmington, and King of Prussia. This GLP-1 receptor agonist is widely studied for appetite regulation, glycemic control, and body composition pathways in laboratory models. Each vial is research-use-only and carries third-party COA documentation so investigators can confirm purity and identity.
An extensively studied GLP-1 receptor agonist with a long half-life enabling once-weekly dosing. Research has investigated its GLP-1 receptor-mediated effects on metabolic signaling pathways and incretin pharmacology.
Semaglutide is studied as a representative GLP-1 receptor agonist for probing incretin pathways and energy-metabolism signaling in vitro. Along the Northeast's pharma and research corridor, Philadelphia investigators, with collaborators in King of Prussia, Cherry Hill, and Wilmington, characterize its receptor affinity and molecular stability in preclinical assays, keeping every experiment within research-only, non-clinical frameworks.
Semaglutide is worked with by researchers throughout the Philadelphia metro — including King of Prussia, Cherry Hill, Wilmington, Camden — and across East Coast. The Northeast's pharma and research corridor. Every ReVia-branded lot carries its own certificate of analysis, and the compound is intended strictly for research use.
Where do researchers in Philadelphia research facility obtain Semaglutide?
These compounds are supplied through i2b Health, ReVia's research partner, to researchers in Philadelphia and surrounding King of Prussia, Cherry Hill, and Wilmington under research-use-only terms. All supply is tracked.
Is Semaglutide third-party tested?
Every lot carries an independent Certificate of Analysis. Researchers can review purity and identity data before beginning work.
What is Semaglutide researched for?
It is a GLP-1 receptor agonist studied in preclinical models for appetite regulation, glycemic control, and body composition research. It is for laboratory use only and is not intended for human use.
For research use only. Not for human or veterinary use. The information on this page is provided for educational and research purposes and does not constitute medical advice.